Sovato

Sovato develops a comprehensive platform designed to facilitate remote robotic surgery and procedures. This innovative system leverages mature robotic-assisted technology, advancements in virtual care, and robust telecommunications infrastructure to enable surgeons to safely and seamlessly perform operations from a distance. The company focuses on making high-quality surgical care scalable and commercially viable across various healthcare settings.

The company was co-founded by Yulun Wang, Ph.D., and Cynthia Perazzo, MBA. Wang, serving as Executive Chairman, brings significant pedigree from his prior role as founder of Computer Motion, where he led the development of the ZEUS system, pivotal in the historic Operation Lindbergh:the first transatlantic remote surgery. Sovato builds directly upon this foundational insight into accessible surgical technology, with Perazzo as CEO.

Sovato’s solutions are intended for healthcare systems looking to expand access to specialized robotic surgery. The ultimate beneficiaries are patients, as the company’s vision is to ensure equitable access to the highest quality surgical care for everyone, regardless of geographic location. This forward-looking approach aims to redefine the delivery of advanced medical procedures globally.

Sovato is a healthcare technology company building a platform to enable and scale *remote robotic surgery and procedure programs* (telesurgery) for health systems and surgical robotics partners, with a stated mission to expand access to high-quality surgical care anywhere[3][2].

High-Level overview

• Mission: Sovato’s stated mission is to create access to the highest-quality surgery and procedures for everyone, everywhere by enabling safe, scalable, and economically sustainable remote surgery programs for healthcare organizations[3][2].
  - Investment/partnership backing and positioning: Sovato has raised institutional capital and strategic investor support (Series B led by Beringea, with participation from Polaris Partners, Intuitive, Teladoc Health and others) to scale its platform[3][1].
  - Key sectors: Sovato sits at the intersection of surgical robotics, telehealth/telesurgery, fiber/low-latency networks, and hospital operations[2][3].
  - Impact on the startup/healthcare ecosystem: By offering an end-to-end orchestration platform that integrates clinical workflows, network infrastructure, and robotic systems, Sovato aims to create a practical market for remote surgery—potentially expanding reach of surgical specialists, improving utilization of robotic platforms, and enabling new care models for health systems and device makers[2][3].

Origin story

• Founding and leadership: Sovato was founded in 2022 and is co‑founded by Cynthia Perazzo, MBA, and Yulun Wang, PhD—an industry veteran who founded Computer Motion and InTouch Health[2][3].
  - Early evolution and milestones: The company headquartered in Santa Barbara, California, quickly focused on a platform approach (not just a single device) that ties together network connectivity, clinical workflows, and partner robotic systems[2][3]. In June 2024 Sovato demonstrated multiple remote robotic-assisted procedures over roughly 500 miles across four specialties, showing early technical and clinical proof-of-concept[2].
  - Funding trajectory: Sovato closed a $41M Series B in November 2025 led by Beringea, bringing institutional and strategic investor support from robotics and telehealth incumbents to accelerate platform development and partnerships[3][1].

Core differentiators

• Platform-first, ecosystem orchestration: Sovato emphasizes an *all-encompassing platform* that connects healthcare systems, robotic systems, surgical teams, and a curated fiberoptic network rather than supplying a single robot[2][3].
  - Network and latency engineering: The company provides low‑latency, fiber‑optic connectivity and supporting infrastructure designed specifically for the timing-sensitive requirements of remote robotic procedures[2].
  - Clinical workflows and program support: Sovato packages clinical workflows, data and operational orchestration to support an entire remote surgery program from referral through postop care—addressing nontechnical barriers to scale[2].
  - Strategic partnerships and investor signal: Backing from surgical-robotics incumbents and telehealth acquirers (e.g., Intuitive and Teladoc Health among investors) both validates Sovato’s approach and opens technical and go‑to‑market channels[3][1].
  - Demonstrated multi-specialty procedures: Early in‑field demonstrations included nephrectomy, hysterectomy, colectomy, and cholecystectomy performed by multiple surgeons across specialties, which supports cross-specialty applicability[2].

Role in the broader tech and healthcare landscape

• Trend alignment: Sovato rides two converging trends—wider adoption of surgical robotics and maturation of telehealth/remote care infrastructure—which together make remote robotic procedures technically and commercially more feasible[4][2].
  - Why timing matters: Advances in robotic systems, improved connectivity (low-latency networks), and growing health-system pressure to extend specialist access and optimize OR utilization create a favorable window for a platform that lowers the operational friction of remote programs[2][3].
  - Market forces in its favor: Health systems seeking to expand access to specialists, device manufacturers aiming to increase utilization of robotic fleets, and payers/providers interested in regionalized care models all create demand for orchestration and safety layers that Sovato offers[2][3].
  - Influence on ecosystem: If Sovato’s platform is adopted at scale, it could accelerate the commercial viability of telesurgery by reducing integration burden for hospitals and robotics vendors and by creating standardized workflows and network approaches that others can build on[2][3].

Quick take & future outlook

• Near term priorities: Sovato will likely focus on commercializing its platform with health systems, deepening integrations with surgical-robotic manufacturers, and expanding the geographic reach and clinical breadth of demonstrated procedures using its low‑latency network and orchestration stack[3][2].
  - Key trends that will shape its path: Regulatory clarity on remote surgery, reimbursement models that recognize value of remote procedures, continued improvements in network latency and surgical-robot interfaces, and buy-in from hospital systems and device OEMs will determine pace of adoption[2][3].
  - Potential upside and risks: Upside includes enabling better access to specialist surgery and more efficient utilization of robotic platforms; risks include regulatory hurdles, liability and credentialing complexities, and the need to prove consistent clinical and economic outcomes at scale[2][3].
  - Final note: Sovato’s platform approach—backed by strategic investors and early multi‑specialty demonstrations—positions it as a primary orchestrator in the emerging telesurgery market, with the next 12–24 months critical for translating demonstrations into repeatable, reimbursed programs[3][2].